Graves眼病患者血浆细胞因子浓度与临床活动度的相关性分析

doi:10.3969/j.issn.1006-7795.2023.03.008

首都医科大学学报 ›› 2023, Vol. 44 ›› Issue (3): 407-412.doi: 10.3969/j.issn.1006-7795.2023.03.008

• 内分泌研究与临床实践 • 上一篇下一篇

Graves眼病患者血浆细胞因子浓度与临床活动度的相关性分析

谢荣荣¹，史婷婷²，信中²，曹曦¹，杨金奎^1，2*

1. 北京市糖尿病研究所/北京市糖尿病防治办公室，北京 100730; 2. 首都医科大学附属北京同仁医院内分泌科，北京 102600

收稿日期:2023-03-01 出版日期:2023-06-21 发布日期:2023-06-08
通讯作者: 杨金奎 E-mail:jkyang@ccmu.edu.cn
基金资助:
北京市医管局“培育计划”项目（PX2021006）, 首都医科大学校培育基金（PYZ21090）,首都医科大学附属北京同仁医院青年人才院内种子基金项目(2020-YJJ-ZZL-012)

Analysis of the correlation between levels of cytokines and the clinical active severity in patients with Graves ophthalmopathy

Xie Rongrong¹，Shi Tingting², Xin Zhong², Cao Xi¹, Yang Jinkui^1,2*

1. Beijing Diabetes Research Institute/Diabetes Prevention and Control Office of Beijing Municipality, Beijing 100730, China; 2. Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University, Beijing 102600, China

Received:2023-03-01 Online:2023-06-21 Published:2023-06-08
Supported by:
This study was supported by Beijing Municipal Administration of Hospitals Incubating Program (PX2021006), Foundation of Capital Medical University (PYZ21090)，the Priming Scientific Research Foundation for the Junior Researcher in Beijing Tongren Hospital, Capital Medical University (2020-YJJ-ZZL-012).

摘要/Abstract

摘要： 目的 Graves眼病(Graves' ophthalmopathy,GO) 是一种器官特异性自身免疫疾病，是成人最常见的眼眶疾病之一，其导致的眼部损害给患者带来了沉重的身心负担。GO的发病机制包括炎症细胞（淋巴细胞、浆细胞、肥大细胞和巨噬细胞）增多，分泌多种细胞因子导致炎症反应。在本研究中，测定活动期及非活动期GO患者血浆12种细胞因子的浓度，探讨其与疾病临床活动度的相关性。方法选取2021年1月－2023月1月在首都医科大学附属北京同仁医院内分泌科诊断为GO患者27例，并按照其临床活动性评分(Clinical Activity Score，CAS)将其划分为活动期组(CAS≥3)14例及非活动期组(CAS<3)13例。采用多重微球流式免疫荧光发光法检测血浆12项细胞因子［包括白细胞介素(interleukin, IL)-1β、IL-2、IL-4、IL-5、IL-6、IL-8、IL-10、IL-17、IL-12P70，干扰素(interferon, IFN)-α、IFN-γ、肿瘤坏死因子(tumor necrosis factor, TNF)-α］浓度，同时收集所有研究对象的性别、年龄、肝肾功能、甲状腺功能及抗体等临床指标。结果与非活动期组相比，活动期GO患者的IL-1、IL-4、IL-5、IL-8、IL-10、IL-17、TNF-α及IFN-γ浓度明显升高，差异均有统计学意义(P<0.05)。 Spearman相关性分析显示IL-1、IL-4、IL-5、IL-8、IL-10、IL-17、TNF-α及IFN-γ与CAS评分呈现显著正相关。单因素Logistic回归分析显示IL-1、IL-4、IL-5和IL-17升高会增加活动期风险。结论（1）活动期GO患者IL-1、IL-4、IL-5、IL-8、IL-10、IL-17、TNF-α及IFN-γ浓度明显高于非活动期组，提示这些细胞因子可能参与了GO的免疫反应。（2）单因素回归分析显示，IL-1、IL-4、IL-5和IL-17升高会增加活动期风险，推测这4种细胞因子有望作为评判GO病情活动性的指标。

关键词: Graves眼病, 活动期病变, 非活动期病变, 细胞因子, 白细胞介素, 临床活动度评分

Abstract: Objective To explore the correlation between plasma levels of 12 cytokines and the clinical activity of the disease in patients with Graves' ophthalmopathy (GO) in active and inactive phases. Methods A total of 27 patients with GO were enrolled, who were diagnosed in the Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University from January 2021 to January 2023. According to their Clinical Activity Score (CAS), the patients were divided into active phase group (14 cases, CAS ≥ 3) and inactive phase group (13 cases, CAS<3) The levels of 12 cytokines in plasma were measured by multiple microsphere flow immunofluorescence luminescence method, including interleukin (IL)-1β IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-17, IL-12P70, interferon (IFN)-α, IFN-γ, and tumor necrosis factor (TNF)-α. The clinical characteristics such as gender, age, liver and kidney function, thyroid function, and antibody of all the subjects were collected. Results The levels of IL-1, IL-4, IL-5, IL-8, IL-10, IL-17, IFN-γ and TNF-α in active GO patients were significantly higher than those in inactive GO patients. Levels of TNF-α and IFN-γ were significantly increased in active GO patients, with statistically significant difference (P<0.05). Spearman correlation analysis showed that IL-1, IL-4, IL-5, IL-8, IL-10, IL-17, TNF-α and IFN-γ were significantly positively correlated with CAS score （P< 0.05）. The univariate logistic regression showed that the elevated levels of IL-1, IL-4, IL-5 and IL-17 increase the risk of active phase. Conclusion The levels of IL-1, IL-4, IL-5, IL-8, IL-10 and IL-17 in active GO patients are significantly higher than those in inactive patients, suggesting that these cytokines may participate in the immune response of the disease. Elevated levels of IL-1, IL-4, IL-5 and IL-17 increase the risk of active phase, indicating a potential of these four cytokines as indicators for judging the activity of GO disease.

Key words: Graves' ophthalmopathy, active phase, inactive phase, cytokines, interleukin, clinical activity scoreGraves

中图分类号:

谢荣荣, 史婷婷, 信中, 曹曦, 杨金奎. Graves眼病患者血浆细胞因子浓度与临床活动度的相关性分析[J]. 首都医科大学学报, 2023, 44(3): 407-412.

Xie Rongrong, Shi Tingting, Xin Zhong, Cao Xi, Yang Jinkui. Analysis of the correlation between levels of cytokines and the clinical active severity in patients with Graves ophthalmopathy[J]. Journal of Capital Medical University, 2023, 44(3): 407-412.

参考文献

［1］Subekti I, Soewondo P, Soebardi S, et al. Practical guidelines management of Graves ophthalmopathy［J］. Acta Med Indones, 2019, 51(4): 364－371.
［2］Antonelli A, Fallahi P, Elia G, et al. Graves disease: clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy ［J］. Best Pract Res Clin Endocrinol Metab, 2020, 34(1):101388.
［3］Mishra S, Maurya V K, Kumar S, et al. Clinical management and therapeutic strategies for the thyroid-associated ophthalmopathy: current and future perspectives［J］. Curr Eye Res, 2020, 45(11):1325－1341.
［4］Fallahi P, Ferrari S M, Elia G, et al. Cytokines as targets of novel therapies for Graves ophthalmopathy［J］. Front Endocrinol (Lausanne),2021, 12:654473.
［5］Jiang M, Zhao J, Wang P, et al. Research progress in Th17 cells and the relevant cytokines in Graves ophthalmopathy［J］. J Central South Univ (Med Ed), 2022, 47(12):1748－1753.
［6］Huang Y, Wu Y, Zhang S, et al. Immunophenotype of lacrimal glands in Graves orbitopathy: implications for the pathogenesis of Th1 and Th17 immunity［J］. Thyroid, 2022,32(8):949－961.
［7］Wang N, Chen F E, Long Z W. Mechanism of microRNA-146a/Notch2 signaling regulating IL-6 in Graves ophthalmopathy［J］. Cell Physiol Biochem, 2017,41(4):1285－1297.
［8］Sánchez-Bilbao L, Martínez-López D, Revenga M, et al. Anti-IL-6 receptor tocilizumab in refractory Graves orbitopathy: national multicenter observational study of 48 patients［J］. J Clin Med,2020, 9(9):2816.
［9］Chen Q. The expression of interleukin-15 and interleukin-17 in tears and orbital tissues of Graves ophthalmopathy patients［J］. J Cell Biochem, 2019, 120(4):6299－6303.
［10］Du J, Wang X, Tan G, et al. Predisposition to Graves disease and Graves ophthalmopathy by genetic variants of IL2RA［J］. J Mol Med, 2021, 99(10):1487－1495.
［11］Wu T, Mester T, Gupta S, et al. Thyrotropin and CD40L stimulate interleukin-12 expression in fibrocytes: implications for pathogenesis of thyroid-associated ophthalmopathy［J］. Thyroid, 2016, 26(12):1768－1777.
［12］Fernando R, Caldera O, Smith T J. Therapeutic IGF-I receptor inhibition alters fibrocyte immune phenotype in thyroid-associated ophthalmopathy ［J］. Proc Natl Acad Sci U S A, 2021, 118(52):e2114244118.
［13］Gonnella D. The Th1 chemokine MIG in Graves ophthalmopathy［J］. Clin Ter, 2019, 170(5):e368-e372.
［14］Kishazi E, Dor M, Eperon S, et al. Differential profiling of lacrimal cytokines in patients suffering from thyroid-associated orbitopathy［J］. Sci Rep, 2018, 8(1):10792.
［15］Song R H, Wang B, Yao Q M, et al. Proteomics screening of differentially expressed cytokines in tears of patients with Graves ophthalmopathy［J］. Endocr Metab Immune Disord Drug Targets, 2020, 20(1):87－95.
［16］Fang S, Huang Y, Wang N, et al. Insights into local orbital immunity: evidence for the involvement of the Th17 cell pathway in thyroid-associated ophthalmopathy［J］. J Clin Endocrinol Metab,2019, 104(5):1697－1711.
［17］Fang S, Lu Y, Huang Y, et al. Mechanisms that underly T cell immunity in Graves orbitopathy［J］. Front Endocrinol (Lausanne), 2021, 12:648732.
［18］Shan J, Jin H, Xu Y. T cell metabolism: a new perspective on Th17/Treg cell imbalance in systemic lupus erythematosus［J］. Front Immunol, 2020, 11:1027.
［19］Dong W, Zhu P. Functional niche of inflamed synovium for Th17-cell expansion and activation in rheumatoid arthritis: implication to clinical therapeutics［J］. Autoimmun Rev, 2012, 11(12):844－851.
［20］Kociuszko M, Popawska-Kita A, Pawowski P, et al. Clinical relevance of estimating circulating interleukin-17 and interleukin-23 during methylprednisolone therapy in Graves orbitopathy: a preliminary study［J］. Adv Med Sci, 2021,66(2):315－320.
［21］Mu P W, Tang X X, Wang Y N, et al. Comparison of two regimens for patients with thyroid-associated ophthalmopathy receiving intravenous methyl prednisolone: A single center prospective randomized trial［J］. Exp Ther Med, 2020,20(6):153.

[1]	冯晓彤, 柯静, 朱琳, 赵冬. 糖尿病视网膜病变的病理生理学研究进展[J]. 首都医科大学学报, 2023, 44(3): 420-423.
[2]	刘畅, 郭默宁, 袁颖超, 郑建鹏, 杨金奎. 2013至2018年北京地区1型糖尿病发病率性别差异及预测[J]. 首都医科大学学报, 2023, 44(3): 370-374.
[3]	李雨阳, 朱晓蓉, 刘婧, 郑晓敏, 杨金奎, 杨芳远. 糖尿病肾病患者触珠蛋白基因多态性及血清触珠蛋白浓度分析[J]. 首都医科大学学报, 2023, 44(3): 375-380.
[4]	李晓辉, 尹洁, 刘冰, 于恒池, 祝英娜, 马池发, 袁明霞. 三酰甘油－葡萄糖指数与脂肪组织胰岛素抵抗的关系分析[J]. 首都医科大学学报, 2023, 44(3): 393-399.
[5]	郑晓敏, 李彬, 刘翠平, 周迎生, 崔丽梅. 老年2型糖尿病患者黎明现象的分析和对策[J]. 首都医科大学学报, 2023, 44(3): 400-406.
[6]	李明嘉, 赵苗妙, 杨金奎. 组织蛋白酶在糖尿病及糖尿病肾病作用机制中的研究进展[J]. 首都医科大学学报, 2023, 44(3): 413-419.
[7]	苏志燕, 刘薇, 史婷婷. 老年2型糖尿病患者血尿酸浓度与代谢综合征的相关性分析[J]. 首都医科大学学报, 2023, 44(1): 137-142.
[8]	郭月红, 黄京伟, 常玉婷, 杨敏福. ^99mTc-MIBI平面显像及断层显像诊断原发性甲状旁腺功能亢进的效能评价[J]. 首都医科大学学报, 2022, 43(6): 873-879.
[9]	王华, 史婷婷, 信中, 华琳, 李聪, 曹秋梅. Graves病患者促甲状腺素受体抗体与肠道菌群及短链脂肪酸的相关性[J]. 首都医科大学学报, 2022, 43(6): 931-939.
[10]	安宇, 边南南, 丁小雨, 常晓娜, 刘佳, 王广. 1型糖尿病伴认知功能损伤小鼠脑组织肠道菌群代谢物的改变[J]. 首都医科大学学报, 2022, 43(4): 622-629.
[11]	修双玲, 付俊玲, 穆志静, 孙丽娜, 赵蕾. 老年2型糖尿病患者体脂率对肌力和躯体功能的影响[J]. 首都医科大学学报, 2022, 43(4): 641-646.
[12]	宋丽敏, 李思源, 李军, 赵会荣, 李佳佳, 王双. 新疆石河子地区绝经后2型糖尿病女性SOST基因联合LRP5基因多态性及突变与骨代谢关系的研究[J]. 首都医科大学学报, 2022, 43(2): 269-274.
[13]	修双玲, 孙丽娜, 穆志静, 付俊玲, 赵蕾. 不同方法校正的肌肉质量与老年2型糖尿病躯体功能的相关性比较[J]. 首都医科大学学报, 2022, 43(2): 284-288.
[14]	姚舒洋, 李小雪, 王淳秀, 张毅. 埃克替尼联合抗血管药物一线治疗EGFR突变晚期肺腺癌的单中心研究[J]. 首都医科大学学报, 2022, 43(2): 289-293.
[15]	熊枫然, 卢晶, 张英超, 谢荣荣, 赵儒轩, 李奇, 杨金奎. Kcnh6点突变单基因糖尿病家系的小鼠模型构建及表型分析[J]. 首都医科大学学报, 2021, 42(4): 575-581.

Graves眼病患者血浆细胞因子浓度与临床活动度的相关性分析

Analysis of the correlation between levels of cytokines and the clinical active severity in patients with Graves ophthalmopathy

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价